##plugins.themes.bootstrap3.article.main##

Chemotherapy-induced nausea and vomiting (CINV) prevention is important to reduce overall morbidity and financial burden in patients receiving chemotherapy. Severe symptoms reduce the patient's quality of life and can interfere with further treatment. The five major forms of CINV (ie, acute, delayed, predicted, breakthrough, and refractory) often include 5-HT3 receptor antagonists, NK1 receptor antagonists, and various treatments that often include corticosteroids. Despite significant research and development efforts on antiemetics, treatment of CINV remains a major challenge, waiting for many needs to be adequately addressed, including those that are vulnerable to CINV despite adequately treated. This review hope to raise awareness and discuss current current CINV management.

Downloads

Download data is not yet available.

References

  1. G. Dranitsaris, A. Molassiotis, M. Clemons. The development of a prediction tool to identify cancer patients at high risk for chemotherapy-induced nausea and vomiting, Ann. Oncol. 2017;28(6):1260–1267.
    DOI  |   Google Scholar
  2. D. Lorusso, E. Bria, A. Costantini, M. Di Maio, G. Rosti, A. Mancuso, Patients’ perception of chemotherapy side effects: expectations, doctor-patient communication and impact on quality of life – An Italian survey, Eur. J. Cancer Care (Engl.) 2017;26 (2):.
    DOI  |   Google Scholar
  3. M. de Boer-Dennert, R. de Wit, P.I. Schmitz. Patient perceptions of the side effects of chemotherapy: the influence of 5HT3 antagonists, Br. J. Cancer. 1997;76 (8):1055–1061.
    DOI  |   Google Scholar
  4. Sommariva S, Pongiglione B, Tarricone R. Impact of chemotherapy-induced nausea and vomiting on health-related quality of life and resource utilization: a systematic review. Crit Rev Oncol Hematol. 2016;99:13-36. doi: 10.1016/j.critrevonc.2015.12.001.
    DOI  |   Google Scholar
  5. Koth SM, Kolesar J. New options and controversies in the management of chemotherapy-induced nausea and vomiting. Am J Health Syst Pharm. 2017;74(11):812-819. doi: 10.2146/ajhp160227.
    DOI  |   Google Scholar
  6. Lorusso V, Russo A, Giotta F, Codega P. Management of Chemotherapy-Induced Nausea and Vomiting (CINV): A Short Review on the Role of Netupitant-Palonosetron (NEPA). Core Evid. 2020;15:21-29. doi:10.2147/CE.S203634.
    DOI  |   Google Scholar
  7. Navari RM. Treatment of breakthrough and refractory chemotherapy-induced nausea and vomiting. Biomed Res Int. 2015;2015:1-6. doi: 10.1155/2015/595894.
    DOI  |   Google Scholar
  8. Navari RM. Management of chemotherapy-induced nausea and vomiting. Drugs. 2013;73(3):249-262. doi: 10.1007/s40265-013-0019-1.
    DOI  |   Google Scholar
  9. Natale, JJ. Overview of the Prevention and Management of CINV. Am J Manag Care. 2018;24:S391-S397.
     Google Scholar
  10. Latreille J, Pater J, Johnston D. Use of dexamethasone and granisetron in the control of delayed emesis for patients who receive highly emetogenic chemotherapy. National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol. Mar; 1998 16(3):1174–1178. [PubMed: 9508205].
    DOI  |   Google Scholar
  11. Morrow GR, Hickok JT, Rosenthal SN. Progress in reducing nausea and emesis. Comparisons of ondansetron (Zofran), granisetron (Kytril), and tropisetron (Navoban). Cancer. Aug 1; 1995 76(3): 343–357. [PubMed: 8625113].
    DOI  |   Google Scholar
  12. Herrstedt J, Dombernowsky P. Anti-emetic therapy in cancer chemotherapy: current status. Basic Clin Pharmacol Toxicol. Sep; 2007 101(3):143–150. [PubMed: 17697032].
    DOI  |   Google Scholar
  13. Lee J, Dodd M, Dibble S, Abrams D. Review of Acupressure Studies for Chemotherapy-Induced Nausea and Vomiting Control. Journal of Pain and Symptom Management. November; 2008 36(5): 529–544. [PubMed: 18440769].
    DOI  |   Google Scholar
  14. Ryan JL, Heckler C, Dakhil SR. Ginger for chemotherapy-related nausea in cancer patients: A URCC CCOP randomized, double-blind, placebo-controlled clinical trial of 644 cancer patients. Journal of Clinical Oncology. 2009; 27(15s) suppl abstr 9511.
    DOI  |   Google Scholar
  15. Gupta K, Walton R, Kataria SP. Chemotherapy-Induced Nausea and Vomiting: Pathogenesis, Recommendations, and New Trends. Cancer Treat Res Commun. 2021;26:100278. doi:10.1016/j.ctarc.2020.100278
    DOI  |   Google Scholar
  16. P.L. Andrews, G.J. Sanger, Abdominal vagal afferent neurones: an important target for the treatment of gastrointestinal dysfunction, Curr. Opin. Pharmacol. 2 (6) (2002) 650–656.
    DOI  |   Google Scholar
  17. R.M. Navari, M. Aapro, Antiemetic prophylaxis for chemotherapy-induced nausea and vomiting, N. Engl. J. Med. 374 (14) (2016) 1356–1367.
    DOI  |   Google Scholar
  18. Ryan JL, Heckler CE, Roscoe JA, et al. Ginger (zingiber officinale) reduces acute chemotherapy induced nausea: a URCC CCOP study of 576 patients. Support Care Cancer. 2012;20(7):1479-1489. doi:10.1007/s00520-011-1236-3.
    DOI  |   Google Scholar
  19. Pillai AK, Sharma KK, Gupta YK, Bakhshi S. Anti-emetic effect of ginger powder versus placebo as an add-on therapy in children and young adults receiving high emetogenic chemotherapy. Pediatr Blood Cancer. 2011;56(2):234-238. doi: 10.1002/pbc.22778.
    DOI  |   Google Scholar
  20. Panahi Y, Saadat A, Sahebkar A, Hashemian F, Taghikhani M, Abolhasani E. Effect of ginger on acute and delayed chemotherapy-induced nausea and vomiting: a pilot, randomized, open-label clinical trial. Integr Cancer Ther. 2012;11(3):204-211. doi: 10.1177/1534735411433201.
    DOI  |   Google Scholar
  21. Zick SM, Ruffin MT, Lee J. Phase II trial of encapsulated ginger as a treatment for chemotherapy induced nausea and vomiting. Support Care Cancer. 2009;17(5):563-572. doi: 10.1007/s00520-008-0528-8.
    DOI  |   Google Scholar
  22. Fahimi F, Khodadad K, Amini S, Naghibi F, Salamzadeh J, Baniasadi S. Evaluating the effect of zingiber officinalis on nausea and vomiting in patients receiving cisplatin based regimens. Iran J Pharm Res IJPR. 2011;10(2):379-384.
     Google Scholar
  23. Bossi P, Cortinovis D, Fatigoni S. A randomized, double-blind, placebo-controlled, multicenter study of a ginger extract in the management of chemotherapy-induced nausea and vomiting (CINV) in patients receiving high-dose cisplatin. Ann Oncol Off J Eur Soc Med Oncol. 2017;28(10):2547-2551. doi: 10.1093/annonc/mdx315.
    DOI  |   Google Scholar
  24. Mustian KM, Devine K, Ryan JL. Treatment of nausea and vomiting during chemotherapy. US Oncol Hematol. 2011;7(2): 91-97. doi: 10.17925/OHR.2011.07.2.91.
    DOI  |   Google Scholar


Most read articles by the same author(s)

1 2 3 > >>